FDA Inspection 1325692 — Haolang Medical USA Corporation
The FDA completed an inspection of Haolang Medical USA Corporation on July 1, 2026 in Clyde Hill, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 1, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Clyde Hill, WA (United States)